Mean change ± standard deviation in A1C and body weight in patients with type 1 diabetes treated with insulin plus either pramlintide or placebo

Reproduced with permission from: Buse J, Weyer C, Maggs D. Amylin replacement with pramlintide in type 1 and type 2 diabetes: A physiological approach to overcome barriers with insulin therapy. Clinical Diabetes 2002; 20:137. Copyright © 2002 The American Diabetes Association.